Publications

Home » Publications
Export 14 results:
Filters: Keyword is Infant  [Clear All Filters]
2024
Arzika AM, Abdou A, Maliki R, Beido N, Kadri B, Harouna AN, Galo AN, Alio MK, Lebas E, Oldenburg CE et al..  2024.  Prolonged mass azithromycin distributions and macrolide resistance determinants among preschool children in Niger: A sub-study of a cluster-randomized trial (MORDOR).. PLoS Med. 21(5):e1004386.
2021
O'Brien KS, Arzika AM, Amza A, Maliki R, Ousmane S, Kadri B, Nassirou B, Mankara AKaramba, Harouna ANaser, Colby E et al..  2021.  Age-based targeting of biannual azithromycin distribution for child survival in Niger: an adaptive cluster-randomized trial protocol (AVENIR).. BMC Public Health. 21(1):822.
2020
Digitale J, Sie A, Coulibaly B, Ouermi L, Dah C, Tapsoba C, Bärnighausen T, Lebas E, Arzika AM, Glymour MMaria et al..  2020.  Gut Bacterial Diversity and Growth among Preschool Children in Burkina Faso.. Am J Trop Med Hyg. 103(6):2568-2573.
Oldenburg CE, Hinterwirth A, Sie A, Coulibaly B, Ouermi L, Dah C, Tapsoba C, Cummings SL, Zhong L, Chen C et al..  2020.  Gut Resistome After Oral Antibiotics in Preschool Children in Burkina Faso: A Randomized, Controlled Trial.. Clin Infect Dis. 70(3):525-527.
Doan T, Worden L, Hinterwirth A, Arzika AM, Maliki R, Abdou A, Zhong L, Chen C, Cook C, Lebas E et al..  2020.  Macrolide and Nonmacrolide Resistance with Mass Azithromycin Distribution.. N Engl J Med. 383(20):1941-1950.
Hinterwirth A, Sie A, Coulibaly B, Ouermi L, Dah C, Tapsoba C, Zhong L, Chen C, Lietman TM, Keenan JD et al..  2020.  Rapid Reduction of Species in the Gut Microbiome of Preschool Children after Oral Azithromycin: A Randomized Controlled Trial.. Am J Trop Med Hyg. 103(3):1266-1269.
Doan T, Hinterwirth A, Arzika AM, Worden L, Chen C, Zhong L, Oldenburg CE, Keenan JD, Lietman TM.  2020.  Reduction of Coronavirus Burden With Mass Azithromycin Distribution.. Clin Infect Dis. 71(16):2282-2284.
2019
Sie A, Ouattara M, Bountogo M, Bagagnan C, Coulibaly B, Boudo V, Lebas E, Brogdon JM, Lin Y, Bärnighausen T et al..  2019.  A double-masked placebo-controlled trial of azithromycin to prevent child mortality in Burkina Faso, West Africa: Community Health with Azithromycin Trial (CHAT) study protocol.. Trials. 20(1):675.
Ray KJ, Cotter SY, Arzika AM, Kim J, Boubacar N, Zhou Z, Zhong L, Porco TC, Keenan JD, Lietman TM et al..  2019.  High-throughput sequencing of pooled samples to determine community-level microbiome diversity.. Ann Epidemiol. 39:63-68.
Keenan JD, Arzika AM, Maliki R, Boubacar N, Adamou SElh, Ali MMoussa, Cook C, Lebas E, Lin Y, Ray KJ et al..  2019.  Longer-Term Assessment of Azithromycin for Reducing Childhood Mortality in Africa.. N Engl J Med. 380(23):2207-2214.
Doan T, Arzika AM, Hinterwirth A, Maliki R, Zhong L, Cummings S, Sarkar S, Chen C, Porco TC, Keenan JD et al..  2019.  Macrolide Resistance in MORDOR I - A Cluster-Randomized Trial in Niger.. N Engl J Med. 380(23):2271-2273.
Sie A, Bountogo M, Nebie E, Ouattara M, Coulibaly B, Bagagnan C, Zabre P, Lebas E, Brogdon J, Godwin WW et al..  2019.  Neonatal azithromycin administration to prevent infant mortality: study protocol for a randomised controlled trial.. BMJ Open. 9(9):e031162.
2018
Keenan JD, Bailey RL, West SK, Arzika AM, Hart J, Weaver J, Kalua K, Mrango Z, Ray KJ, Cook C et al..  2018.  Azithromycin to Reduce Childhood Mortality in Sub-Saharan Africa.. N Engl J Med. 378(17):1583-1592.
2017
Doan T, Arzika AM, Ray KJ, Cotter SY, Kim J, Maliki R, Zhong L, Zhou Z, Porco TC, Vanderschelden B et al..  2017.  Gut Microbial Diversity in Antibiotic-Naive Children After Systemic Antibiotic Exposure: A Randomized Controlled Trial.. Clin Infect Dis. 64(9):1147-1153.